First basic environmental performance requirements for medical devices defined by Quality First International
An article published by London-based medical device regulatory consultancy Quality First International conceives the first environmentally-related requirements for medical devices as it is time that sustainability and eco-friendliness become topics of discussion in the industry.
London, 5 December 2019
Quality First International (QFI) has published an article in the November 2019 issue of the Journal of Medical Device Regulation which outlines the very first Basic Environmental Performance Requirements (BEPR) for medical devices.
“The environmental impact of medical devices, their contribution to pollution, plus their sustainability, receive no attention” says the author Haroon Atchia, CEO and Chief Technical Officer at QFI. “However, they should be considered hugely significant factors considering the quantities of medical devices used globally.”
The article proposes a number of Basic Environmental Performance Requirements (BEPR) to define attributes that sustainable medical devices should achieve in order to promote good medical device environmental quality through fundamental design and construction to ensure high-performing, environmentally-healthy products with the lowest possible environmental waste potential.
“It is hoped that these BEPR will inspire improved medical device design to establish medical device environmental, green and sustainability state-of-the-art concepts”, confirms Atchia.
The article may be ordered from the Global Regulatory Press website – GlobalRegulatoryPress.com – or by email to firstname.lastname@example.org. Price: £50 (plus VAT as applicable). Reference: “Basic Environmental Performance Requirements for medical devices: Attributes for eco-friendly, green and sustainable medical devices (November 2019)”.
About Quality First International (QFI)
QFI is a London-based medical devices consulting company specialising in solving its clients’ regulatory, technical and compliance challenges to enable medical devices to enter the global marketplace. QFI provides regulatory advice, quality assurance and clinical trial services, with particular emphasis on the European, US, Japanese, Australian, Canadian, Mexican and Chinese marketplaces. All submissions made by QFI have fulfilled the compliance requirements first time round, consistently. QFI’s clients range from start-up companies to multinational organisations, primarily developing a broad range of cutting edge, minimally invasive and cardiovascular products and implants. QFI also specialises in various remediation and business excellence initiatives including solutions to regulatory enforcement, corporate integrity arrangements and expert witness services.
For further information please contact:
Tel: +44 (0)208 221 2361, Email: email@example.com, Website: www.qualityfirstint.com.